Released Aug 6, 2018, after the close
10-Q filed Aug 6, 2018, 37 days after period end · 0001564590-18-019507
Q2 2018 · 10-Q
Revenue$111.55M$111.55M +2.4% vs Q2 2017+2.6% vs Q1 2018
Net Income$925.00K$925.00K −76.0% vs Q2 2017−82.3% vs Q1 2018
EPS Diluted$0.05$0.05 −76.2% vs Q2 2017−81.5% vs Q1 2018
Gross Profit$88,712,000+3.4%
Operating Income$5,915,000−26.0%
Operating Cash Flowderived$16,592,000+165.2%
Free Cash Flowderived$13,641,000+363.5%
Margins · derived
Gross margin79.5%+0.8 pt vs Q2 2017
Operating margin5.3%−2.0 pt vs Q2 2017
Net margin0.8%−2.7 pt vs Q2 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $111.55M | $108.94M | $104.08M | $100.95M |
| Net Income | $925.00K | $3.85M | -$7.44M | $3.57M |
| EPS Diluted | $0.05 | $0.21 | -$0.41 | $0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR